Phase II double blind placebo controlled trial using chimeric anti-CD4 in treating patients with methotrexate refractory rheumatoid arthritis. Results of the study have not yet been analyzed. UAB enrolled 26 of the 60 patients in this multicenter trial.
Showing the most recent 10 out of 570 publications